Page last updated: 2024-10-18

glycocyamine and Cardiovascular Diseases

glycocyamine has been researched along with Cardiovascular Diseases in 7 studies

glycocyamine: RN given refers to parent cpd; structure
guanidinoacetate : A monocarboxylic acid anion that is the conjugate base of guanidinoacetic acid, obtained by deprotonation of the carboxy group.
guanidinoacetic acid : The N-amidino derivative of glycine.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanff, E1
Said, MY1
Kayacelebi, AA1
Post, A1
Minovic, I1
van den Berg, E1
de Borst, MH1
van Goor, H1
Bakker, SJL1
Tsikas, D1
Ostojic, SM2
Trivic, T1
Drid, P1
Stajer, V1
Vranes, M2
Loncar, D1
Zenic, N1
Sekulic, D1
BORSOOK, H2
BORSOOK, ME2
GRAYBIEL, A1
PATTERSON, CA1
Andrade, F1
Rodríguez-Soriano, J1
Prieto, JA1
Elorz, J1
Aguirre, M1
Ariceta, G1
Martin, S1
Sanjurjo, P1
Aldámiz-Echevarría, L1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effects of Medium-term Oral Guanidinoacetic Acid (GAA) Administration on Human Performance, Body Composition, and Metabolic Outcomes in Physically Active Men and Women[NCT01133899]Phase 1/Phase 240 participants (Actual)Interventional2010-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for glycocyamine and Cardiovascular Diseases

ArticleYear
Effects of Guanidinoacetic Acid Loading on Biomarkers of Cardiometabolic Risk and Inflammation.
    Annals of nutrition & metabolism, 2018, Volume: 72, Issue:1

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Dietary Supplements; Fema

2018

Other Studies

6 other studies available for glycocyamine and Cardiovascular Diseases

ArticleYear
High plasma guanidinoacetate-to-homoarginine ratio is associated with high all-cause and cardiovascular mortality rate in adult renal transplant recipients.
    Amino acids, 2019, Volume: 51, Issue:10-12

    Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Cross-Sectional Studies; Female; Follow-Up Stu

2019
Guanidinoacetic Acid and Creatine are Associated with Cardiometabolic Risk Factors in Healthy Men and Women: A Cross-Sectional Study.
    Nutrients, 2018, Jan-13, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Chroma

2018
The biochemical basis of betaine-glycocyamine therapy.
    Annals of western medicine and surgery, 1951, Volume: 5, Issue:10

    Topics: Betaine; Biochemical Phenomena; Cardiovascular Diseases; Creatine; Glycine; Humans

1951
Treatment of cardiac decompensation with betaine and glycocyamine.
    Annals of western medicine and surgery, 1951, Volume: 5, Issue:10

    Topics: Betaine; Biochemical Phenomena; Cardiovascular Diseases; Creatine; Glycine; Heart Failure; Humans

1951
Use of betaine and glycocyamine in the treatment of patients with heart disease: preliminary report.
    Annals of western medicine and surgery, 1951, Volume: 5, Issue:10

    Topics: Betaine; Cardiovascular Diseases; Creatine; Glycine; Heart Diseases; Humans

1951
The arginine-creatine pathway is disturbed in children and adolescents with renal transplants.
    Pediatric research, 2008, Volume: 64, Issue:2

    Topics: Adolescent; Arginine; Cardiovascular Diseases; Case-Control Studies; Child; Creatine; Creatinine; Fe

2008